COVID-19
The Latest
-
China’s COVID-19 Struggles Continue As Chengdu Extends Lockdowns
The number of new locally transmitted diseases reported each day in Chengdu has generally been under 200. The number of new locally transmitted diseases reported each day in Chengdu has generally been under 200. -
China Approves CanSino's Inhaled COVID-19 Vaccine For Emergency Use
CanSino has received approval from the National Medical Products Administration. CanSino has received approval from the National Medical Products Administration. -
Shenzhen, China Adopts COVID-19 New Tiers To Curb Outbreak
Shenzhen will divide its areas into three categories based on the risk of infection: low, medium, and high. Shenzhen will divide its areas into three categories based on the risk of infection: low, medium, and high. -
Updated COVID Boosters For BA.5 Receives FDA Approval
Depending on the CDC's approval, new boosters from Moderna and Pfizer may be distributed in the next few days. Depending on the CDC's approval, new boosters from Moderna and Pfizer may be distributed in the next few days. -
U.S. Businesses' Optimism Toward China Registers New Low
Around 96% of enterprises were affected by China's COVID-19 measures. Around 96% of enterprises were affected by China's COVID-19 measures. -
COVID-19’s Mental Health Impact On China Youth
China has some of the most stringent COVID-19 rules, imposing lengthy lockdowns for months. China has some of the most stringent COVID-19 rules, imposing lengthy lockdowns for months. -
COVID Shot Demand Weakens In China Resulting In Lower CanSinoBIO Revenue In H1
Weaker demand for the COVID-19 vaccination was the main cause of the fall from 2.06 billion yuan (U.S. $299.8 million) to 629.8 million yuan. Weaker demand for the COVID-19 vaccination was the main cause of the fall from 2.06 billion yuan (U.S. $299.8 million) to 629.8 million yuan. -
Flu Caused Fever Cases In Locked-Down Province, North Korea Says
North Korea has never confirmed the number of people sick with COVID-19. North Korea has never confirmed the number of people sick with COVID-19. -
Paxlovid COVID-19 Pill Effective For Elderly But May Not Benefit Young Adults
When administered soon after infection, Paxlovid reduced hospitalizations among those 65 and older by almost 75%, according to the study. When administered soon after infection, Paxlovid reduced hospitalizations among those 65 and older by almost 75%, according to the study. -
China: Births, Marriages Have Declined Due To COVID-19
Some Chinese people's marriage and childbearing arrangements were clearly impacted by the coronavirus. Some Chinese people's marriage and childbearing arrangements were clearly impacted by the coronavirus.